You have 9 free searches left this month | for more free features.

Condition

Hepatitis B (1)

Hepatitis B Virus (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Bristol-Myers Squibb (1)

GlaxoSmithKline (1)

Collaborator

Intervention

pegifn (2)

entecavir (1)

gsk3228836 (1)

na therapy (1)

pegifn lambda (1)

pegifnα-2a (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

pegifn

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hepatitis B Trial in Worldwide (GSK3228836, PegIFN, NA therapy)

Active, not recruiting

Hepatitis B

GSK3228836
+2 more

Sacramento, California
+48 more

Jan 19, 2023

Hepatitis B Virus Trial in Worldwide (pegIFN, pegIFNa-2a, PegIFN lambda)

Completed

Hepatitis B Virus

pegIFN
+3 more

Anaheim, California
+52 more

Sep 23, 2015